King's College London

Research portal

Regulation of cardiac contractile function by troponin I phosphorylation

Research output: Contribution to journalLiterature review

Standard

Regulation of cardiac contractile function by troponin I phosphorylation. / Layland, J; Solaro, R J; Shah, A M.

In: Cardiovascular Research, Vol. 66, No. 1, 01.04.2005, p. 12 - 21.

Research output: Contribution to journalLiterature review

Harvard

Layland, J, Solaro, RJ & Shah, AM 2005, 'Regulation of cardiac contractile function by troponin I phosphorylation', Cardiovascular Research, vol. 66, no. 1, pp. 12 - 21. https://doi.org/10.1016/j.cardiores.2004.12.022

APA

Layland, J., Solaro, R. J., & Shah, A. M. (2005). Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovascular Research, 66(1), 12 - 21. https://doi.org/10.1016/j.cardiores.2004.12.022

Vancouver

Layland J, Solaro RJ, Shah AM. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovascular Research. 2005 Apr 1;66(1):12 - 21. https://doi.org/10.1016/j.cardiores.2004.12.022

Author

Layland, J ; Solaro, R J ; Shah, A M. / Regulation of cardiac contractile function by troponin I phosphorylation. In: Cardiovascular Research. 2005 ; Vol. 66, No. 1. pp. 12 - 21.

Bibtex Download

@article{e88438b967ec4c3da3af5fdbce921428,
title = "Regulation of cardiac contractile function by troponin I phosphorylation",
abstract = "Cardiac troponin I (cTnl) is a key regulatory protein in cardiac muscle contraction and relaxation, linking Ca2+ -troponin C binding with activation of crossbridge reactions with the thin filament. In recent years, it has become increasingly apparent that myofilament properties as well as changes in intracellular Ca2+ have a major role in the dynamic modulation of contractile function. The phosphorylation of specific serine and threonine residues on cTnl by several different kinases represents a major physiological mechanism for alteration of myofilament properties. Furthennore, altered thin filament function plays an important role in the contractile dysfunction associated with heart failure. Modification of cTn1 by protein kinases A and C has been extensively studied with especially useful information deriving from (a) in vitro studies in reconstituted detergent-skinned fibre bundles in which endogenous cTn1 was replaced with various targeted cTn1 mutants and (b) transgenic animals in which endogenous cTn1 was similarly manipulated through overexpression of cardiomyocyte-targeted cTn1 mutants. cTn1 may also be specifically modified by protein kinase G, p21-activated kinases and by dephosphorylation. This review focuses on recent advances in understanding the mechanisms of cTn1 modification by these kinases and the consequent functional effects both under physiological conditions and in pathophysiological settings. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved",
author = "J Layland and Solaro, {R J} and Shah, {A M}",
year = "2005",
month = "4",
day = "1",
doi = "10.1016/j.cardiores.2004.12.022",
language = "English",
volume = "66",
pages = "12 -- 21",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Regulation of cardiac contractile function by troponin I phosphorylation

AU - Layland, J

AU - Solaro, R J

AU - Shah, A M

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Cardiac troponin I (cTnl) is a key regulatory protein in cardiac muscle contraction and relaxation, linking Ca2+ -troponin C binding with activation of crossbridge reactions with the thin filament. In recent years, it has become increasingly apparent that myofilament properties as well as changes in intracellular Ca2+ have a major role in the dynamic modulation of contractile function. The phosphorylation of specific serine and threonine residues on cTnl by several different kinases represents a major physiological mechanism for alteration of myofilament properties. Furthennore, altered thin filament function plays an important role in the contractile dysfunction associated with heart failure. Modification of cTn1 by protein kinases A and C has been extensively studied with especially useful information deriving from (a) in vitro studies in reconstituted detergent-skinned fibre bundles in which endogenous cTn1 was replaced with various targeted cTn1 mutants and (b) transgenic animals in which endogenous cTn1 was similarly manipulated through overexpression of cardiomyocyte-targeted cTn1 mutants. cTn1 may also be specifically modified by protein kinase G, p21-activated kinases and by dephosphorylation. This review focuses on recent advances in understanding the mechanisms of cTn1 modification by these kinases and the consequent functional effects both under physiological conditions and in pathophysiological settings. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved

AB - Cardiac troponin I (cTnl) is a key regulatory protein in cardiac muscle contraction and relaxation, linking Ca2+ -troponin C binding with activation of crossbridge reactions with the thin filament. In recent years, it has become increasingly apparent that myofilament properties as well as changes in intracellular Ca2+ have a major role in the dynamic modulation of contractile function. The phosphorylation of specific serine and threonine residues on cTnl by several different kinases represents a major physiological mechanism for alteration of myofilament properties. Furthennore, altered thin filament function plays an important role in the contractile dysfunction associated with heart failure. Modification of cTn1 by protein kinases A and C has been extensively studied with especially useful information deriving from (a) in vitro studies in reconstituted detergent-skinned fibre bundles in which endogenous cTn1 was replaced with various targeted cTn1 mutants and (b) transgenic animals in which endogenous cTn1 was similarly manipulated through overexpression of cardiomyocyte-targeted cTn1 mutants. cTn1 may also be specifically modified by protein kinase G, p21-activated kinases and by dephosphorylation. This review focuses on recent advances in understanding the mechanisms of cTn1 modification by these kinases and the consequent functional effects both under physiological conditions and in pathophysiological settings. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved

U2 - 10.1016/j.cardiores.2004.12.022

DO - 10.1016/j.cardiores.2004.12.022

M3 - Literature review

VL - 66

SP - 12

EP - 21

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454